Picture of Terrascend logo

TSND — Terrascend News Story

0.000.00%
ca flag iconLast trade - 00:00
Consumer DefensivesSpeculativeSmall CapContrarian

Cannabis company TerrAscend Q3 revenue misses estimates

Overview

TerrAscend Q3 revenue of $65.1 mln missed analyst expectations

Company reports Q3 net loss from continuing operations of $9.9 mln

Completed $79 mln refinancing and had said it plans to exit Michigan market by year-end

Outlook

Company evaluating strategic M&A opportunities with a disciplined approach

TerrAscend aims to benefit from potential regulatory changes

Result Drivers

NORTHEAST MARKETS - Revenue stability supported by consistent performance in New Jersey, Maryland, and Pennsylvania

REFINANCING - Completed $79 mln non-dilutive refinancing of existing debt for strategic M&A

MARYLAND GROWTH - Maryland revenue increased 14.8% year-over-year with high gross margins

Key Details

MetricBeat/MissActualConsensus Estimate
Q3 RevenueMiss$65.10 mln$66.03 mln (4 Analysts)
Q3 EPSMiss-$0.08-$0.02 (4 Analysts)
Q3 Gross Margin52.10%
Q3 Net Income from Cont. Ops-$9.90 mln
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell" The average consensus recommendation for the drug retailers peer group is "buy" Wall Street's median 12-month price target for Terrascend Corp is C$2.00, about 51.5% above its November 5 closing price of C$0.97 Press Release: ID:nGNX8g5F0K For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Terrascend

See all news